This is from the Q2 release so I would imagine that November is the month like yosef wrote-but you never know they could always surprise everyone with an early release
"We are also very pleased with the progress of the Phase 2 clinical trial for BL-8040, a best-in-class CXCR4 antagonist for the treatment of hematological cancers such as AML. We are on track to deliver partial results from the trial in the fourth quarter of 2013, with final results expected to be available by the second half of 2014."
of course it can not go up every single day and the big fish need an opportunity to get in so they shake out the week ones like us.
This stock is a winner imo and you should buy on days like this. Extremely undervalued and they just added a first of its kind diabetes drug to there already big portfolio..